Pharmanovia

Pharmanovia is a global lifecycle management company that specializes in maximizing the potential of established medicines. With a keen focus on patient and clinician insights, Pharmanovia identifies ongoing unmet needs and leverages its expertise to deliver innovative solutions that enhance patient outcomes. The company boasts a diverse portfolio across multiple therapeutic areas, including cardiovascular treatments like Inderal® and Zestril®, endocrinology products such as Bonviva® and Rocaltrol®, and neurology medications including Anaprox® and Valium®. Additionally, Pharmanovia offers oncology solutions like Bondronat® and Kytril®, addressing critical health challenges across the globe.

With over 15 offices worldwide and a presence in more than 160 markets, Pharmanovia collaborates with a range of partners, including innovative pharmaceutical firms and tech platforms, to improve healthcare sustainably. Their commitment to inclusivity and development fosters a dynamic environment for employees, driving the company forward in its mission to enhance patient care and community well-being.